Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
August 2015 Vol 8, Special Issue: Payers' Perspectives in Oncology
Value-Based Healthcare Delivery: The Agenda for Oncology
Chase Doyle
Read More
Emerging Therapies
Nivolumab Beats Docetaxel as Second-Line Therapy for Patients with NSCLC
Phoebe Starr
Read More
Searching for the Tipping Point in Drug Pricing
Caroline Helwick
Read More
Emerging Therapies
Oncology Pipeline Full, and Not Just with Immunotherapies
Caroline Helwick
,
Wayne Kuznar
Read More
FDA Approvals
FDA Update
Read More
Aetna Examines Impact of Site of Service on Chemotherapy Cost
Caroline Helwick
Read More
Treating with Checkpoint Inhibitors—Figure $1 Million per Patient
Audrey Andrews
Read More
Researchers Dissect the Cost of Targeted Agents
Caroline Helwick
Read More
Bevacizumab Wins Cost-Effectiveness Contest in First-Line Metastatic Colorectal Cancer
Caroline Helwick
Read More
Will Necitumumab Be Cost-Effective?
Caroline Helwick
Read More
1
2
3
4
Page 1 of 4
Results 1 - 10 of 37
